Evidence map›Paper›PMID 33658924›Full record

ArticleFrontiers in pharmacology2020

Cytotoxicity Evaluation of Chloroquine and Hydroxychloroquine in Multiple Cell Lines and Tissues by Dynamic Imaging System and Physiologically Based Pharmacokinetic Model.

Jianling Yang, Zhengyang Guo, Xu Liu, Qi Liu, Meng Wu, Xueting Yao, Yang Liu, Cheng Cui, Haiyan Li, Chunli Song and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Integrating Chemo- and Bioinformatics withJournal of chemical information and modeling · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Plasma membrane repair defect in Alzheimer's disease neurons is driven by the reduced dysferlin expression.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Frontiers in pharmacology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Jianling YangCenter of Basic Medicine Research (CBMR), Peking University Third Hospital, Beijing, China.
Zhengyang GuoCenter of Basic Medicine Research (CBMR), Peking University Third Hospital, Beijing, China.
Xu LiuDrug Clinical Trial Center, Peking University Third Hospital, Beijing, China.
Qi LiuDrug Clinical Trial Center, Peking University Third Hospital, Beijing, China.
Meng WuCenter of Basic Medicine Research (CBMR), Peking University Third Hospital, Beijing, China.
Xueting YaoDrug Clinical Trial Center, Peking University Third Hospital, Beijing, China.
Yang LiuCenter of Basic Medicine Research (CBMR), Peking University Third Hospital, Beijing, China.
Cheng CuiDrug Clinical Trial Center, Peking University Third Hospital, Beijing, China.
Haiyan LiDrug Clinical Trial Center, Peking University Third Hospital, Beijing, China.
Chunli SongDepartment of Orthopedics, Peking University Third Hospital, Beijing, China.
Dongyang LiuDrug Clinical Trial Center, Peking University Third Hospital, Beijing, China.
Lixiang XueCenter of Basic Medicine Research (CBMR), Peking University Third Hospital, Beijing, China.
Peking University · CNPeking University Third Hospital · CNUniversity of Chinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chloroquine (CQ) and hydroxychloroquine (HCQ) have been challenged in treating COVID-19 patients and still under debate due to the uncertainty regarding the effectiveness and safety, and there is still lack of the systematic study on the toxicity of these two drugs. To further uncover the toxicity profile of CQ and HCQ in different tissues, we evaluated the cytotoxicity of them in eight cell lines and further adopted the physiologically based pharmacokinetic models to predict the tissue risk, respectively. Retina, myocardium, lung, liver, kidney, vascular endothelium, and intestinal epithelium originated cells were included in the toxicity evaluation of CQ and HCQ, respectively. The proliferation pattern was monitored in 0-72 h by IncuCyte S3. CC50 and the ratio of tissue trough concentrations to CC50 (R

Indexed as

chloroquine and hydroxychloroquinecytotoxicitydynamic imaging systemphysiologically based pharmacokinetic modelratio of tissue trough concentrations

Identifiers

PMID33658924
PMCPMC7919379
OpenAlexW3108665741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.